Suzhou Basecare Medical Dividends and Buybacks
Dividend criteria checks 0/6
Suzhou Basecare Medical does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Suzhou Basecare Medical (HKG:2170) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Nov 18
Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) Low P/S
Sep 27Here's Why Shareholders May Want To Be Cautious With Increasing Suzhou Basecare Medical Corporation Limited's (HKG:2170) CEO Pay Packet
May 30Suzhou Basecare Medical Corporation Limited's (HKG:2170) Shares Leap 27% Yet They're Still Not Telling The Full Story
May 09Suzhou Basecare Medical Corporation Limited (HKG:2170) Screens Well But There Might Be A Catch
Mar 22Is There An Opportunity With Suzhou Basecare Medical Corporation Limited's (HKG:2170) 47% Undervaluation?
Aug 01Lacklustre Performance Is Driving Suzhou Basecare Medical Corporation Limited's (HKG:2170) 27% Price Drop
May 26Are Investors Undervaluing Suzhou Basecare Medical Corporation Limited (HKG:2170) By 48%?
Jul 20Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 2170's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 2170's dividend payments have been increasing.
Dividend Yield vs Market
| Suzhou Basecare Medical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2170) | n/a |
| Market Bottom 25% (HK) | 3.2% |
| Market Top 25% (HK) | 8.0% |
| Industry Average (Medical Equipment) | 3.3% |
| Analyst forecast (2170) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate 2170's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 2170's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 2170's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 2170 has not reported any payouts.